Litigation Details for Celgene Corporation v. Hetero Labs Limited (S.D. Cal. 2019)
✉ Email this page to a colleague
Celgene Corporation v. Hetero Labs Limited (S.D. Cal. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-08-23 |
| Court | District Court, S.D. California | Date Terminated | 2020-01-06 |
| Cause | 28:1331 Fed. Question | Assigned To | Larry Alan Burns |
| Jury Demand | Referred To | Allison H. Goddard | |
| Patents | 8,198,262; 8,673,939; 8,735,428; 8,828,427; 9,993,467 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Celgene Corporation v. Hetero Labs Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Celgene Corporation v. Hetero Labs Limited (S.D. Cal. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-10-17 | 10 | INVALIDITY CONTENTIONS WITH RESPECT TO U.S. PATENT NOS. 8,198,262; 8,673,939; 8,735,428; AND 8,828,427 …issuance of U.S. Patent Application Nos. 09/899,344 and 10/020,391. Neither of these patent applications… specifically claimed in the MoT Patents. Instead, EntreMed’s patent applications 04841-00022/10006308.1… on the inventorship of the MoT Patents. The claims of the MoT Patents cover specific methods of treating… (c) The ’733 patent Defendants rely on the ’733 patent for its alleged teaching | External link to document | |
| 2020-01-02 | 19 | Order on Motion to Quash | that ultimately issued as asserted U.S. Patent Nos. 8,198,262 and 8,828,427 for Plaintiff. 8 ECF No… are five patents-in-suit, comprising two 14 families of related patents: (1) U.S. Patent Nos. 8,198,262…and file a patent application, … and prosecute the patent application 20 through the Patent Office.’”…12 Patent No. 9,993,467 for Plaintiff. Id. at 5, 7. He continues to represent Plaintiff in patent 13 …issues of substantive patent law and certain 27 procedural issues pertaining to patent law, but applies | External link to document |
| 2019-10-17 | 9 | Response in Opposition to Motion | 8,198,262, 8,673,939, and 8,735,428, which are directed to methods of treating multiple 18 myeloma…There are five patents-in-suit, comprising two families of related patents: U.S. Patent Nos. 17 8,198,262…pomalidomide (“MOT Patents”), and U.S. Patent Nos. 8,828,427 (“the ’427 19 patent”) and 9,993,467 (…Art Patents that Defendants Primarily Rely Upon for the MOT Patents. ...…subpoenas on prosecution counsel of the patents-in- 3 suit in a patent infringement action in the District | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
